Novo Nordisk | Ventes



Sales Changement Date
ANI Pharmaceuticals USD 190.6M 42.3M 2024-12
Aurora Cannabis CAD 88.2M 7.08M 2024-12
Bausch Health Companies USD 2.56B 50M 2024-12
Bristol-Myers Squibb USD 12.34B 450M 2024-12
Canopy Growth CAD 74.76M 11.77M 2024-12
Corcept Therapeutics USD 181.89M 656K 2024-12
Drreddys Laboratories INR 83.59B 3.42B 2024-12
Eli Lilly USD 13.53B 2.09B 2024-12
GlaxoSmithKline GBP 8.12B 108M 2024-12
Merck USD 15.62B 1.03B 2024-12
Novartis USD 13.15B 330M 2024-12
Novo Nordisk 85.68B 14.37B 2024-12
Novo Nordisk DKK 85.68B 14.37B 2024-12
Pacira USD 187.25M 18.68M 2024-12
Perrigo USD 1.14B 50.8M 2024-12
Prestige Brands USD 290.32M 6.53M 2024-12
Sanofi EUR 10.56B 2.88B 2024-12
Supernus Pharmaceuticals USD 174.16M 1.53M 2024-12
Zoetis USD 2.32B 71M 2024-12



Novo Nordisk Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Mar 2025.